Sort By

  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • David Chaplin

  • Drew Meredith

  • Giselle Roux

  • Greg Bright

  • Ishan Dan

  • James Dunn

  • Lachlan Maddock

  • Owen Raszkiewicz

Biotech BARD1 cancer detection treatment gaining traction

BARD1 Life Sciences (ASX: BD1) – Earlier in the week, the Inside Investor team published an article on BARD1 Life Sciences (click here) and its meteoric rise following a positive announcement on ovarian cancer detection. Shares have risen from 74.5c on the day of the announcement to $3.20 at the time of writing. That’s a…
Ishan Dan | 17th Feb 2021 | More
Biotech share doubles on positive cancer announcement

BARD1 Life Sciences (ASX: BD1) – The Melbourne-based biotech’s shares rocketed 132 per cent following a positive announcement last Thursday on ovarian cancer detection. The company said Griffith University’s Institute of Glycomics had released data showing that the company’s licensed SubB2M technology can be used to detect all stages of ovarian cancer with 100% specificity…
Ishan Dan | 14th Feb 2021 | More